| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JCEM.77.5.8077323 |
| P8608 | Fatcat ID | release_ynlquaps3zexxj5eur446gk6aq |
| P698 | PubMed publication ID | 8077323 |
| P2093 | author name string | Wing R | |
| Kelley DE | |||
| Sturis J | |||
| Buonocore C | |||
| Fitzsimmons M | |||
| Polonsky K | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calorie restriction | Q1332886 |
| P304 | page(s) | 1287-1293 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus | |
| P478 | volume | 77 |
| Q35904835 | A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism? |
| Q36580294 | A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes |
| Q43105420 | A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet |
| Q53802117 | Adipose tissue transcriptomics and epigenomics in low birthweight men and controls: role of high-fat overfeeding. |
| Q35060170 | Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes |
| Q39228891 | Bile acids and bariatric surgery |
| Q47759489 | Caloric Restriction-Induced Decreases in Dopamine Receptor Availability are Associated with Leptin Concentration. |
| Q40590809 | Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity |
| Q36479829 | Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms |
| Q35147057 | Current management strategies for coexisting diabetes mellitus and obesity |
| Q51374872 | Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. |
| Q57160228 | Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs |
| Q37179529 | Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction |
| Q37110503 | Does caloric restriction alone explain the effects of Roux-en-Y gastric bypass on glucose metabolism? Not by a long limb |
| Q59297363 | Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes |
| Q43179099 | Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. |
| Q36292243 | Effects of bariatric surgery on glucose homeostasis and type 2 diabetes |
| Q37226877 | Endocrine and metabolic response to gastric bypass |
| Q45092471 | Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. |
| Q37557234 | Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important? |
| Q34032047 | Fasting plasma leptin level is a surrogate measure of insulin sensitivity |
| Q60046771 | Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements |
| Q35620195 | Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy |
| Q34545348 | High calorie intake is associated with worsening insulin resistance and β-cell function in Hispanic women after gestational diabetes mellitus. |
| Q37105254 | Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes |
| Q37050850 | Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome |
| Q33932757 | Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide |
| Q46720328 | Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures |
| Q43290988 | Increased susceptibility to oxidative damage in post-diabetic human myotubes |
| Q42874791 | Incretin-based therapy and the quest for sustained improvements in β-cell health |
| Q34096908 | Insulin resistance with aging: effects of diet and exercise |
| Q36848937 | Insulin sensitivity: modulation by nutrients and inflammation |
| Q36860187 | Insulin-stimulated Glut 4 translocation in human skeletal muscle: a quantitative confocal microscopical assessment |
| Q36235156 | Intermittent energy restriction in type 2 diabetes: A short discussion of medication management |
| Q35691789 | Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats |
| Q35450715 | Is acetylation a metabolic rheostat that regulates skeletal muscle insulin action? |
| Q88155293 | Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect |
| Q90680833 | Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery |
| Q36736362 | Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging |
| Q33688563 | Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes |
| Q36840914 | Metabolic surgery for type 2 diabetes with BMI <35 kg/m(2) : an endocrinologist's perspective |
| Q37275992 | Metreleptin improves blood glucose in patients with insulin receptor mutations |
| Q35130620 | Modest weight loss improves insulin action in obese African Americans. |
| Q47369939 | Multi-factorial approach associated with a new 'on/off' Orlistat® use in a weight loss maintenance programme: 4 years follow-up |
| Q28082002 | Natural history of β-cell adaptation and failure in type 2 diabetes |
| Q36565675 | Nutrient restriction and radiation therapy for cancer treatment: when less is more |
| Q26824738 | Nutritional modulation of insulin resistance |
| Q28505328 | Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice |
| Q33757051 | Preoperative weight gain might increase risk of gastric bypass surgery. |
| Q36740436 | Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions |
| Q37106477 | Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? |
| Q36974279 | Reversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis. |
| Q35963032 | Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery |
| Q37639656 | Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery |
| Q51245449 | Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission. |
| Q36945310 | SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabete |
| Q35768126 | Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection |
| Q35992525 | Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes |
| Q35087568 | Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? |
| Q34211446 | Skeletal muscle utilization of free fatty acids in women with visceral obesity |
| Q61796715 | Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes |
| Q47238539 | Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats |
| Q36867612 | Spillover of Fatty acids during dietary fat storage in type 2 diabetes: relationship to body fat depots and effects of weight loss |
| Q34023422 | Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults |
| Q48143632 | The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion |
| Q36609182 | The association between measurement sites of visceral adipose tissue and cardiovascular risk factors after caloric restriction in obese Korean women |
| Q38045820 | The effect of gastrointestinal surgery on insulin resistance and insulin secretion |
| Q34474453 | The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women |
| Q33569142 | The metabolic syndrome |
| Q33761529 | The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery |
| Q37634244 | The treatment of type 2 diabetes |
| Q26828760 | Use of metformin in diseases of aging |
| Q37110587 | Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients |
| Q35132986 | Weight Loss as a Cure for Type 2 Diabetes? Fact or Fantasy |
| Q35462085 | Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study |
| Q55555487 | What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? |
| Q33816658 | β-cell function after weight-loss induced by bariatric surgery |
Search more.